KEY TAKEAWAYS
- Ambiguous genitalia is two emergencies at once: a medical one (exclude/treat salt-wasting congenital adrenal hyperplasia, which can be fatal) and a psychosocial one (the family needs prompt, sensitive support) — but sex assignment must not be rushed.
- Prioritize CAH: measure 17-hydroxyprogesterone in every neonate with atypical genitalia (especially with non-palpable gonads), and monitor electrolytes for salt-wasting crisis.
- Classify by karyotype (Chicago Consensus): 46,XX DSD (most commonly CAH — a virilized female), 46,XY DSD (undervirilized male — androgen insensitivity, 5-alpha-reductase deficiency, etc.), and sex chromosome DSD.
- Palpable gonads are a major clue — a palpable gonad usually indicates testicular tissue (points away from CAH/46,XX).
- Care is multidisciplinary — pediatric endocrinology, urology/surgery, genetics, gynecology, psychology, social work, neonatology — at an experienced center.
- Communicate sensitively — avoid guessing the sex before evaluation; use neutral language and support the family.
1. Clinical Overview
Clinical Overview
Disorders (or differences) of sex development are conditions in which the chromosomal, gonadal, and anatomic sex are not concordant, and they often present at birth as atypical (ambiguous) genitalia. The birth of such an infant is genuinely urgent — not because sex must be assigned immediately (it must not be rushed), but because the commonest and most dangerous underlying cause, congenital adrenal hyperplasia, can precipitate a life-threatening salt-wasting crisis in the first weeks, and because the family needs immediate, compassionate guidance. The modern standard is prompt referral to an experienced multidisciplinary team, a structured evaluation (examination, karyotype, hormones, imaging), and a careful, unhurried, family-centered process of diagnosis and sex-of-rearing decision-making.
2. Definitions (Chicago Consensus classification)
| Category | Meaning / common causes |
|---|
| 46,XX DSD | Typically virilized female — most commonly CAH (21-hydroxylase deficiency); also maternal androgen exposure, aromatase deficiency. |
| 46,XY DSD | Typically undervirilized male — androgen insensitivity (partial/complete), 5-alpha-reductase deficiency, testosterone-biosynthesis defects, gonadal dysgenesis. |
| Sex chromosome DSD | Turner (45,X), Klinefelter (47,XXY), mixed gonadal dysgenesis (45,X/46,XY), ovotesticular DSD. |
| DSD | Umbrella term for atypical chromosomal/gonadal/anatomic sex. |
| Prader staging | Grading of external virilization in 46,XX DSD. |
3. Pathophysiology (framework)
Pathophysiology (framework)
Sex development proceeds from chromosomal sex → gonadal sex → anatomic sex, directed by genes (e.g., SRY) and hormones (testosterone/DHT, AMH). DSD arises when a step is disrupted:
- 46,XX virilization: excess androgen exposure (CAH — cortisol block diverts precursors to androgens; maternal/placental androgen sources).
- 46,XY undervirilization: inadequate androgen production or action (biosynthesis defects, 5-alpha-reductase deficiency, androgen insensitivity) or gonadal dysgenesis.
- Sex chromosome variations: abnormal gonadal development (mixed gonadal dysgenesis, ovotesticular DSD).
4. Clinical Presentation & Examination Clues
Clinical Presentation & Examination Clues
- Atypical external genitalia: clitoromegaly, labioscrotal fusion, micropenis, hypospadias, undescended/absent gonads, discordance between genitalia and any prenatal sex prediction.
- Palpable gonads: a palpable gonad (especially bilateral) usually indicates testicular tissue → points toward 46,XY (or ovotesticular) and away from CAH/46,XX (which has non-palpable gonads).
- Hyperpigmentation (ACTH excess → suggests CAH).
- Dysmorphism/other anomalies (syndromic DSD).
- History: maternal virilization/androgen exposure, consanguinity, family history of DSD/CAH/neonatal deaths/infertility.
5. Diagnostic Approach
Diagnostic Approach
Two priorities: (1) exclude/treat CAH; (2) do not rush sex assignment.
- History and careful examination (palpable gonads, phallus size, urethral/vaginal openings, Prader stage, dysmorphism, blood pressure).
- Karyotype (with rapid X/Y detection; SRY).
- Hormones — prioritize CAH: 17-hydroxyprogesterone (elevated in 21-hydroxylase-deficiency CAH) in all with atypical genitalia and absent inguinal swellings; plus electrolytes (salt-wasting). Additional: DHEA, 17-hydroxypregnenolone, 11-deoxycortisol, testosterone/DHT ratio, gonadotropins, AMH, and stimulation tests as directed.
- Imaging: pelvic/abdominal ultrasound (uterus, gonads); genitography/MRI; sometimes vaginoscopy/laparoscopy/gonadal biopsy.
- Refer immediately to the multidisciplinary DSD team at an experienced center.
6. Management
Management
Immediate
- Exclude/treat CAH — if salt-wasting CAH is present, treat the adrenal crisis urgently (IV fluids + stress-dose hydrocortisone; see the CAH chapter) and start maintenance therapy.
- Support the family — sensitive, honest communication; use neutral language ("your baby") and avoid announcing a sex before evaluation.
Diagnostic and decision-making process
- Multidisciplinary team (pediatric endocrinology, urology/surgery, genetics, gynecology, psychology, social work, neonatology) coordinates evaluation and counseling.
- Sex-of-rearing decision is made carefully and unhurriedly, based on the specific diagnosis, anatomy, potential for function and fertility, and family values — some diagnoses (e.g., CAH in 46,XX; complete androgen insensitivity in 46,XY) can be decided relatively quickly; others take time.
- Avoid rushed, irreversible genital surgery — contemporary practice emphasizes shared decision-making and, where possible, deferring non-essential/irreversible procedures (an area of active ethical discussion).
Ongoing
- Gonadal tumor risk: dysgenetic gonads containing Y material carry an increased gonadoblastoma/germ-cell-tumor risk → gonadectomy considered per diagnosis.
- Long-term endocrine, surgical, psychological, and fertility follow-up.
7. Monitoring
Monitoring
- Electrolytes (salt-wasting CAH) in the first weeks.
- Response to CAH therapy (if applicable — growth, androgens, electrolytes).
- Psychological support for the family (and later the individual).
- Gonadal surveillance (tumor risk) and pubertal/fertility planning over the long term.
8. Complications
Complications
- Salt-wasting adrenal crisis (undiagnosed CAH) — potentially fatal.
- Gonadal tumors (dysgenetic gonads with Y material).
- Psychosocial distress (for family and individual) — mitigated by sensitive, expert care.
- Suboptimal functional/fertility outcomes and complications of surgery (a reason for caution).
9. Safety Warnings
Safety Warnings
- ⚠️ Exclude/treat CAH urgently — measure 17-OHP, monitor electrolytes, and treat any salt-wasting crisis (fluids + stress-dose hydrocortisone).
- ⚠️ Do NOT rush or guess sex assignment — evaluate first; use neutral language with the family.
- ⚠️ Refer to an experienced multidisciplinary team promptly.
- ⚠️ A palpable gonad usually means testicular tissue — a key examination clue.
- ⚠️ Consider gonadal tumor risk with Y material in dysgenetic gonads.
- ⚠️ Handle communication with care — this is a psychosocial as well as medical emergency.
10. Common Mistakes
Common Mistakes
- Missing CAH (not checking 17-OHP/electrolytes) → salt-wasting crisis.
- Announcing/assigning a sex before evaluation.
- Not referring to a multidisciplinary team early.
- Ignoring the palpable-gonad clue.
- Rushing irreversible genital surgery.
- Overlooking gonadal tumor risk.
- Insensitive communication with the family.
11. Clinical Pearls
Clinical Pearls
- 💡 Atypical genitalia = check 17-OHP and electrolytes — CAH is common and dangerous.
- 💡 Don't guess the sex — "your baby" until the team has evaluated.
- 💡 Palpable gonad → think testis (points away from CAH/46,XX).
- 💡 Karyotype + 17-OHP + ultrasound anchor the initial workup.
- 💡 This is a team sport — endocrine, urology, genetics, psychology, social work.
- 💡 Y material in a dysgenetic gonad → tumor risk.
12. Summary Table
Summary Table
| Domain | Bottom line |
|---|
| Two emergencies | Medical (exclude/treat CAH) + psychosocial (support family); don't rush sex assignment |
| Classify | 46,XX DSD (CAH commonest) · 46,XY DSD (AIS, 5-α-reductase, dysgenesis) · sex chromosome DSD |
| Key clue | Palpable gonad → testicular tissue (points away from CAH) |
| Prioritize | 17-hydroxyprogesterone + electrolytes (CAH/salt-wasting) |
| Workup | Karyotype/SRY, hormone panel, pelvic ultrasound (± MRI/genitography/laparoscopy) |
| Care | Multidisciplinary team; unhurried sex-of-rearing decision; caution with irreversible surgery |
| Long-term | Gonadal tumor risk (Y material), endocrine/surgical/psychological/fertility follow-up |
13. Step-by-Step Bedside Algorithm
NEONATE with ATYPICAL (AMBIGUOUS) GENITALIA
│
▼
IMMEDIATE PRIORITIES (in parallel)
1. MEDICAL: exclude/treat CAH → 17-hydroxyprogesterone + ELECTROLYTES
→ salt-wasting crisis? → IV fluids + STRESS-DOSE HYDROCORTISONE (see CAH chapter)
2. PSYCHOSOCIAL: sensitive communication; NEUTRAL language; DON'T assign/announce sex yet
│
▼
REFER to MULTIDISCIPLINARY DSD TEAM (endocrine, urology/surgery, genetics, gynecology, psychology, SW)
│
▼
STRUCTURED EVALUATION
• examination: PALPABLE GONADS? (→ testicular tissue), phallus, openings, Prader stage, BP, dysmorphism
• KARYOTYPE / SRY (rapid X/Y)
• hormones: 17-OHP (+ DHEA, 11-deoxycortisol, testosterone/DHT, gonadotropins, AMH; stimulation as needed)
• IMAGING: pelvic/abdominal ultrasound (uterus/gonads) ± MRI/genitography/laparoscopy
│
▼
CLASSIFY → 46,XX DSD (CAH?) · 46,XY DSD · sex chromosome DSD
│
▼
CAREFUL, UNHURRIED sex-of-rearing decision (diagnosis, anatomy, function/fertility, family values)
• treat CAH; caution/defer irreversible genital surgery (shared decision-making)
• assess GONADAL TUMOR RISK (Y material in dysgenetic gonads)
• long-term endocrine/surgical/psychological/fertility follow-up + family support
14. References to Verify
Confirm each against the primary source before clinical or published use.
- 1.Consensus framework: Hughes IA, et al. Consensus Statement on Management of Intersex Disorders (Chicago Consensus). Arch Dis Child / J Pediatr Endocrinol. 2006, updated 2016 (Lee PA, et al., Global DSD Update). (Verify classification/recommendations.)
- 2.CAH priority: measurement of 17-hydroxyprogesterone and salt-wasting management (Endocrine Society CAH guideline). (Verify.)
- 3.Evaluation: society consensus reports on diagnostic approach (karyotype, hormones, imaging). (Verify.)
- 4.Gonadal tumor risk: references on Y-material dysgenetic gonads and gonadoblastoma risk. (Verify.)
- 5.Ethics/surgery timing: contemporary literature on deferring irreversible genital surgery / shared decision-making. (Verify.)